Document is current
Any future updates will be listed below
-
Authors
Linell, Julia https://orcid.org/0000-0001-9758-3916
Isaxon, Christina https://orcid.org/0000-0002-9105-4017
Olsson, Bo https://orcid.org/0000-0003-4042-3086
Stroh, Emilie https://orcid.org/0000-0001-8724-3897
Wollmer, Per https://orcid.org/0000-0003-2448-9931
Löndahl, Jakob https://orcid.org/0000-0001-9379-592X
Rissler, Jenny https://orcid.org/0000-0001-8650-4741
-
Funding
Funding for this research was provided by:
Svenska Forskningsrådet Formas (2018-00693)
Vetenskapsrådet (2021-03265)
Hjärt-Lungfonden (2020-0855)
Lund University
- License Information
-
More Information
Article History
Received: 7 July 2023
Accepted: 5 December 2023
First Online: 30 December 2023
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Bo Olsson is a major shareholder of Mimetikos AB, Sweden, which owns Preludium<sup>TM</sup>. All other authors declare that no competing interests exist.
